Atul Anand1,2, Sarah Cudmore3, Shirley Robertson3, Jacqueline Stephen4, Kristin Haga3, Christopher J Weir4, Scott A Murray5, Kirsty Boyd5, Julian Gunn6, Javaid Iqbal6, Alasdair MacLullich7, Susan D Shenkin7, Keith A A Fox8, Nicholas Mills8, Martin A Denvir8. 1. BHF Centre for Cardiovascular Science, University of Edinburgh, Room SU.305 Chancellor's Building, Edinburgh, EH16 4SB, UK. atul.anand@ed.ac.uk. 2. Geriatric Medicine Research Group, University of Edinburgh, Edinburgh, UK. atul.anand@ed.ac.uk. 3. Department of Cardiology, Edinburgh Heart Centre, Royal Infirmary of Edinburgh, Edinburgh, UK. 4. Edinburgh Clinical Trials Unit, Usher Institute for Population Health Sciences and Informatics University of Edinburgh, Edinburgh, UK. 5. Primary Palliative Care Research Group, Usher Institute for Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK. 6. South Yorkshire Cardiothoracic Centre, Northern General Hospital, Sheffield, UK. 7. Geriatric Medicine Research Group, University of Edinburgh, Edinburgh, UK. 8. BHF Centre for Cardiovascular Science, University of Edinburgh, Room SU.305 Chancellor's Building, Edinburgh, EH16 4SB, UK.
Abstract
BACKGROUND: Risk prediction after myocardial infarction is often complex in older patients. The Global Registry of Acute Coronary Events (GRACE) model includes clinical parameters and age, but not frailty. We hypothesised that frailty would enhance the prognostic properties of GRACE. METHODS: We performed a prospective observational cohort study in two independent cardiology units: the Royal Infirmary of Edinburgh, UK (primary cohort) and the South Yorkshire Cardiothoracic Centre, Sheffield, UK (external validation). The study sample included 198 patients ≥65 years old hospitalised with type 1 myocardial infarction (primary cohort) and 96 patients ≥65 years old undergoing cardiac catheterisation for myocardial infarction (external validation). Frailty was assessed using the Clinical Frailty Scale (CFS). The GRACE 2.0 estimated risk of 12-month mortality, Charlson comorbidity index and Karnofsky disability scale were also determined for each patient. RESULTS: Forty (20%) patients were frail (CFS ≥5). These individuals had greater comorbidity, functional impairment and a higher risk of death at 12 months (49% vs. 9% in non-frail patients, p < 0.001). The hazard of 12-month all-cause mortality nearly doubled per point increase in CFS after adjustment for age, sex and comorbidity (Hazard Ratio [HR] 1.90, 95% CI 1.47-2.44, p < 0.001). The CFS had good discrimination for mortality by Receiver Operating Characteristic (ROC) curve analysis (Area Under the Curve [AUC] 0.81, 95% CI 0.72-0.89) and enhanced the GRACE estimate (AUC 0.86 vs. 0.80 without CFS, p = 0.04). At existing GRACE thresholds, the CFS resulted in a Net Reclassification Improvement (NRI) of 0.44 (95% CI 0.28-0.60, p < 0.001), largely through reductions in risk estimates amongst non-frail patients. Similar findings were observed in the external validation cohort (NRI 0.46, 95% CI 0.23-0.69, p < 0.001). CONCLUSIONS: The GRACE score overestimated mortality risk after myocardial infarction in these cohorts of older patients. The CFS is a simple guided frailty tool that may enhance prediction in this setting. These findings merit evaluation in larger cohorts of unselected patients. TRIAL REGISTRATION: Clinicaltrials.gov; NCT02302014 (November 26th 2014, retrospectively registered).
BACKGROUND: Risk prediction after myocardial infarction is often complex in older patients. The Global Registry of Acute Coronary Events (GRACE) model includes clinical parameters and age, but not frailty. We hypothesised that frailty would enhance the prognostic properties of GRACE. METHODS: We performed a prospective observational cohort study in two independent cardiology units: the Royal Infirmary of Edinburgh, UK (primary cohort) and the South Yorkshire Cardiothoracic Centre, Sheffield, UK (external validation). The study sample included 198 patients ≥65 years old hospitalised with type 1 myocardial infarction (primary cohort) and 96 patients ≥65 years old undergoing cardiac catheterisation for myocardial infarction (external validation). Frailty was assessed using the Clinical Frailty Scale (CFS). The GRACE 2.0 estimated risk of 12-month mortality, Charlson comorbidity index and Karnofsky disability scale were also determined for each patient. RESULTS: Forty (20%) patients were frail (CFS ≥5). These individuals had greater comorbidity, functional impairment and a higher risk of death at 12 months (49% vs. 9% in non-frail patients, p < 0.001). The hazard of 12-month all-cause mortality nearly doubled per point increase in CFS after adjustment for age, sex and comorbidity (Hazard Ratio [HR] 1.90, 95% CI 1.47-2.44, p < 0.001). The CFS had good discrimination for mortality by Receiver Operating Characteristic (ROC) curve analysis (Area Under the Curve [AUC] 0.81, 95% CI 0.72-0.89) and enhanced the GRACE estimate (AUC 0.86 vs. 0.80 without CFS, p = 0.04). At existing GRACE thresholds, the CFS resulted in a Net Reclassification Improvement (NRI) of 0.44 (95% CI 0.28-0.60, p < 0.001), largely through reductions in risk estimates amongst non-frail patients. Similar findings were observed in the external validation cohort (NRI 0.46, 95% CI 0.23-0.69, p < 0.001). CONCLUSIONS: The GRACE score overestimated mortality risk after myocardial infarction in these cohorts of older patients. The CFS is a simple guided frailty tool that may enhance prediction in this setting. These findings merit evaluation in larger cohorts of unselected patients. TRIAL REGISTRATION: Clinicaltrials.gov; NCT02302014 (November 26th 2014, retrospectively registered).
Authors: Marleen G A M van der Velde; Merel J van der Aa; Merel H C van Daal; Marjolein N T Kremers; Carolina J P W Keijsers; Sander M J van Kuijk; Harm R Haak Journal: BMC Geriatr Date: 2022-07-15 Impact factor: 4.070
Authors: Michał Węgiel; Paweł Kleczyński; Artur Dziewierz; Łukasz Rzeszutko; Andrzej Surdacki; Stanisław Bartuś; Tomasz Rakowski Journal: J Cardiovasc Dev Dis Date: 2022-05-05
Authors: Niels M R van der Sangen; Jaouad Azzahhafi; Dean R P P Chan Pin Yin; Joyce Peper; Senna Rayhi; Ronald J Walhout; Melvyn Tjon Joe Gin; Deborah M Nicastia; Jorina Langerveld; Georgios J Vlachojannis; Rutger J van Bommel; Yolande Appelman; José P S Henriques; Jurriën M Ten Berg; Wouter J Kikkert Journal: Open Heart Date: 2022-03
Authors: Sean G Kelly; Kunling Wu; Katherine Tassiopoulos; Kristine M Erlandson; Susan L Koletar; Frank J Palella Journal: J Acquir Immune Defic Syndr Date: 2021-07-01 Impact factor: 3.771